Literature DB >> 31940650

Ganoderic Acid A Inhibits Bleomycin-Induced Lung Fibrosis in Mice.

Gaoyan Wen1,2, Tian Li2, Hua He2, Xianmei Zhou1,3, Jia Zhu4,5.   

Abstract

BACKGROUND: To study the protective effects of ganoderic acid A (GAA) on bleomycin (BLM)-induced pulmonary fibrosis.
METHODS: ICR mice were intratracheally instilled with BLM to induce pulmonary fibrosis on day 0. Then the mice were orally given GAA (25, 50 mg/kg) or dexamethasone (2 mg/kg). After treatment for 21 days, the mice were sacrificed. Wet dry weight (W/D) ratio of lung was used to detect pulmonary edema. Myeloperoxidase (MPO), interleukin-1β (IL-1β), IL-6, tumor necrosis factor-α (TNF-α), malondialdehyde (MDA), and superoxide dismutase (SOD) were detected by enzyme-linked immunosorbent assay. Hematoxylin and eosin staining was used to evaluate the pathological changes. The levels of transforming growth factor β (TGF-β), phosphorylated-smad3 (p-smad3), p-IκB, and p-nuclear factor-kappa B (NF-κB) in lung tissue were detected by western blot.
RESULTS: GAA treatment significantly improved MPO activity, W/D ratio, and lung histopathology. The protective effect of GAA may be related to downregulation of TNF-α, IL-1β, IL-6, MDA and upregulation of SOD. In addition, GAA significantly decreased the levels of TGF-β, p-smad3, p-IκB, and p-NF-κB, compared with those in BLM group.
CONCLUSION: GAA has protective effect on BLM-induced lung injury, and TGF-β/Smad-3/NF-κB signaling pathway may play an important role in the pathogenesis of BLM-induced lung injury.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Ganoderic acid A; Inflammation; Lung fibrosis; Nuclear factor kappa B; Smad-3; Transforming growth factor -β

Mesh:

Substances:

Year:  2020        PMID: 31940650     DOI: 10.1159/000505297

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  3 in total

1.  Jinlian Xiaodu Decoction Protects against Bleomycin-Induced Pulmonary Fibrosis in Rats.

Authors:  Zhiqiang Wu; Qin He; Feibao Tao; Xuxing Ye; Saibin Wang; Yijun Zhu; Liang Zhu; Bin Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-23       Impact factor: 2.650

2.  Ganoderic Acid A alleviates the degeneration of intervertebral disc via suppressing the activation of TLR4/NLRP3 signaling pathway.

Authors:  Dan Wang; Xianhua Cai; Feng Xu; Hui Kang; Yanjin Li; Ruibing Feng
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 3.  Experimental and Clinical Studies on the Effects of Natural Products on Noxious Agents-Induced Lung Disorders, a Review.

Authors:  Saeideh Saadat; Sima Beigoli; Mohammad Reza Khazdair; Fatemeh Amin; Mohammad Hossein Boskabady
Journal:  Front Nutr       Date:  2022-05-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.